Cell2Cure has entered into a collaboration agreement with Endeavour Cells ApS, to collaborate on the preparation, conduct, management, and completion of an un-blinded phase I/II clinical trial in children with autism.

The clinical trial title is “Effect of adipose derived mesenchymal stromal cells on autism and leaky gut syndrome”.

Endeavour Cells will financially sponsor the trial, but Cell2Cure will have the role as clinical sponsor.
It is expected that the trial will be ready to enroll the first participant early 2023.